brusatol has been researched along with Cancer of Stomach in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, Y; Chen, H; Jiang, T; Li, Q; Su, J; Wang, X | 1 |
1 other study(ies) available for brusatol and Cancer of Stomach
| Article | Year |
|---|---|
Brusatol reverses lipopolysaccharide-induced epithelial-mesenchymal transformation and induces apoptosis through PI3K/Akt/NF-кB pathway in human gastric cancer SGC-7901 cells.
Topics: Apoptosis; Biomarkers, Tumor; Cell Line, Tumor; Cell Survival; Cytokines; Drug Interactions; Epithelial-Mesenchymal Transition; Humans; Lipopolysaccharides; NF-kappa B; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Quassins; Reactive Oxygen Species; Signal Transduction; Stomach Neoplasms | 2021 |